Biocon, announced last week, the inauguration of its State of the art Integrated Research and Development Centre, by Noble Laureate Prof. Kurt Wuthrich.
As a biotechnology research centre with multi-disciplinary capabilities in molecular biology, biologics process sciences, formulation research and preclinical and clinical development, Biocon Research Center (BRC) is a first-of-its kind facility in South-East Asia.
The 200,000ft² will accommodate a team of over 300 scientists. BRC housed in Biocon Park, will be engaged in cutting edge Biologics research. The company aims to attract outstanding scientists from the best institutes around the world and engage with international thought leaders as well as participate in technical programs as an effective way to enable innovation through knowledge sharing.
An independent quality group at BRC will ensure compliance to good laboratory practices (GLP) and international regulatory guidelines for developing ‘best in class’ biologics and biosimilars.
Biocon Group chairman and managing director Kiran Mazumdar-Shaw said: “We aspire to build a centre of research excellence that will pursue an innovation-led effort to develop advanced yet affordable solutions for several debilitating diseases. It will epitomize Biocon’s efforts to galvanize the best talent available both in India and from across the globe, and offer them an intellectually stimulating environment combined with an enabling ecosystem to conduct path breaking research for biopharmaceuticals.”
Source: Biocon press release